
Sarepta Therapeutics Investor Relations Material
Latest events

Status Update
Sarepta Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Sarepta Therapeutics Inc
Access all reports
Sarepta Therapeutics Inc. is a biopharmaceutical company focused on developing genetic medicines for the treatment of rare diseases. The company specializes in RNA-targeted therapies, gene therapy, and gene editing technologies to address neuromuscular and other genetic disorders. The company is headquartered in Cambridge, Massachusetts, and its shares are listed on the NASDAQ.
Key slides for Sarepta Therapeutics Inc


Q4 2024
Sarepta Therapeutics Inc


Q1 2025
Sarepta Therapeutics Inc
Latest articles
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
)
Shuntaro Furukawa: The Sixth President of Nintendo
Shuntaro Furukawa, Nintendo's sixth president, went from a childhood fan to leading the company through global expansion and the launch of Switch 2.
23 Jun 2025
Ticker symbol
SRPT
Country
🇺🇸 United States